Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

LONG-ACTING 3 HIV-DRUGS-IN-ONE NANOPARTICLE FORMULATION INTENDED FOR ADOLESCENTS

By Enthusiast Inc MDMarch 6, 2018

…therapeutics aimed at suppressing HIV in children and adolescents has been limited. In contrast to a larger selection of oral combination antiretroviral therapies (cART) available for adults, the options for…

EARLY bNAb THERAPY IN SHIVAD8-EO–INFECTED RHESUS MACAQUES

By Jimmy He PharmD, DScApril 22, 2021

Co-administration of the anti-HIV-1 bNAbs 10-1074 and 3BNC117 to SHIV-infected monkeys at days 3, 10, and 17 post-challenge led to long-term CD8+ T cell-mediated control of infection in half of…

MK-8591 CONCENTRATIONS AT SITES OF HIV TRANSMISSION AND REPLICATION

By Enthusiast Inc MDFebruary 16, 2017

…enriched in lymphoid tissue (75.9 nmol-eq/g) compared to blood (lymph node:blood ratio = 2.7). MK-8591 remained enriched in lymphoid tissue at 24 hr (11.1 nmol-eq/g; lymph node:blood ratio = 7.1)….

HIV Gag p24 PERSISTS IN TISSUE AND CORRELATES WITH IMMUNE RESPONSE

By Jimmy He PharmD, DScApril 28, 2020

Gut tissue and lymph nodes (LN) harbor HIV DNA and RNA during antiretroviral therapy (ART)–mediated viral suppression, but less is known about HIV protein expression. The goal of this study…

STATEWIDE HIV-1 TRANSMISSION CLUSTER DETECTION AND PRIORITIZATION FOR RESPONSE

By Jimmy He PharmD, DScApril 27, 2020

…from pairwise genetic distances (TN-93), connecting edges <1.5% difference. Prioritization metrics were assessed for clusters with recent diagnoses (2017-2019) and based on the adjacent nodes to recent diagnoses (edges <1.5%),…

THE ROLE OF MIGRATORY DENDRITIC CELLS IN ESTABLISHING HIV DISSEMINATION

By Enthusiast Inc MDMarch 6, 2019

…DC:HIV and DC:T cell interactions within a 3D collagen matrix that recapitulates the stromal networks of the lymph node. Two-photon microscopy was performed to visualize (1) the cellular dynamic of…

HIV DRUG RESISTANCE ACROSS ANATOMICAL TISSUES

By Jimmy He PharmD, DScApril 28, 2020

…of drug resistance across multiple tissues in two persons with HIV. Last Gift study participant 3 (LG03) was a 72-year-old man with HIV and metastatic pancreatic cancer with no previous history…

HIV Transmission Network Structure Reveals Characteristics of Bridging Individuals

By Enthusiast Inc MDFebruary 27, 2015

…metric). Network degree, mean path length (MPL), and betweenness centrality were computed for each network node, and statistical analyses were used to examine which sociodemographic factors associated with network properties….

December 1 is World AIDS Day, a Time to Raise Awareness of the AIDS Pandemic and Remember Its History and Its Toll

Latest NewsBy Michelle ValderamaDecember 1, 2021

…medical education and crucial information to health care practitioners who provide care for people with HIV and AIDS. Your donation will be used to help supply clinicians all around the…

“A” CASE TO REMEMBER: HEPATITIS A – MANAGING AN OLD VIRUS IN NEW POPULATIONS AT RISK

By Jimmy He PharmD, DScApril 28, 2020

This session will use a case-based approach with audience response questions to review important updates in epidemiological risk factors for hepatitis A virus (HAV) infection, unusual presentations and complications that…

←1
2345678910111213141516171819202122232425262728293031323334353637383940414243
…4445464748…
49505152535455565758596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top